Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,930 signal articles · 231 in last 24h · 118,817 total before filter · latest 1h ago
231last 24h
1537last 7d
255● bullish (7d)
159● bearish (7d)
205publishers
AllMacro295Earnings618M&A103Regulatory22Product14Analyst22
✕ clear all filtersSentiment:bullishneutralbearishshow all (incl. clickbait)
Entergy (ETR) Q2 Earnings Top Estimates
Zacks21d agoneutral
Entergy (ETR) Q2 Earnings Top Estimates

Entergy (ETR) delivered earnings and revenue surprises of +9.57% and -0.08%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Cognizant (CTSH) Lags Q2 Earnings Estimates
Zacks21d agoneutral
Cognizant (CTSH) Lags Q2 Earnings Estimates

Cognizant (CTSH) delivered earnings and revenue surprises of -0.73% and +0.03%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Procter & Gamble Earnings Beat Estimates. This Warning Is Pressuring the Stock.
Barrons.com21d agobullish
Procter & Gamble Earnings Beat Estimates. This Warning Is Pressuring the Stock.

Shares of Procter & Gamble declined in premarket trading Wednesday as Wall Street reacted to mixed quarterly earnings and underwhelming profit guidance from the consumer packaged goods company. Procter & Gamble posted core earnings of $1.43 a share for the fiscal fourth quarter, down from $1.48 a year ago but slightly above Wall Street expectations of $1.41. It was a mixed bag for Procter & Gamble’s product categories—which range from baby care to hair care.

Boston Scientific (NYSE:BSX) Surprises With Q2 CY2026 Sales But Quarterly Revenue Guidance Misses Expectations
StockStory21d agobearish
Boston Scientific (NYSE:BSX) Surprises With Q2 CY2026 Sales But Quarterly Revenue Guidance Misses Expectations

Medical device company Boston Scientific (NYSE:BSX) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 7.5% year on year to $5.44 billion. On the other hand, next quarter’s revenue guidance of $5.27 billion was less impressive, coming in 2.2% below analysts’ estimates. Its non-GAAP profit of $0.86 per share was 3.8% above analysts’ consensus estimates.

United Microelectronics Q2 Earnings Call Highlights
MarketBeat21d agoneutral
United Microelectronics Q2 Earnings Call Highlights

United Microelectronics (NYSE:UMC) reported higher second-quarter revenue, wafer shipments and utilization as demand strengthened in communications and consumer applications, while the company raised its 2026 capital-expenditure budget to support silicon photonics and advanced-packaging growth initi

Ford Shares Rise After Q2 Earnings Beat and Higher Full-Year Guidance
InvestorsHub21d agobullish
Ford Shares Rise After Q2 Earnings Beat and Higher Full-Year Guidance

Ford Motor Company (NYSE:F) shares climbed more than 4% after the automaker reported better-than-expected second-quarter results and raised its financial outlook for the full year, supported by stronger operating performance across its core business. The company posted adjusted earnings per share of $0.

Investing.com21d agobullish
Vertiv shares sink as Q2 revenue miss offsets upgraded guidance

Investing.com -- Shares in Vertiv tumbled more than 9% in premarket trading Wednesday even as the data center equipment maker reported second-quarter earnings above estimates and raised its full-year guidance, with a revenue shortfall offseting the beat.